PainReform (PRFX)

• Market cap: $2.5M
• 1 day: -0.8%
• 5 days: -6.77%
• 1 month: -9.49%
• 3 months: -16.78%
• 6 months: -39.51%
• Year to date: -61.73%
• 1 year: -50.2%
• 5 years: -99.89%
• 10 years: -99.92%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Employees: 6